Paper41998221
Semaphorin 4D (CD100) expression as a predictor for the response to induction therapy in pediatric patients with B-acute lymphoblastic leukemia.
Elkholy RA and 6 others. Eur J Pediatr, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Semaphorin 4D (CD100) expression as a predictor for the response to induction therapy in pediatric patients with B-acute lymphoblastic leukemia. Papers, record 41998221. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41998221
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Semaphorin 4D (CD100) expression as a predictor for the response to induction therapy in pediatric patients with B-acute lymphoblastic leukemia.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Semaphorins | Major topic |
| Antigens, CD | Major topic |
| Induction Chemotherapy | Major topic |
| Biomarkers, Tumor | Major topic |
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | Major topic |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | Major topic |
| Antineoplastic Combined Chemotherapy Protocols | Major topic |
| Humans | |
| Child | |
| Male | |
| Female | |
| Child, Preschool | |
| Prognosis | |
| Adolescent | |
| ROC Curve | |
| Flow Cytometry | |
| Treatment Outcome | |
| Infant | |
| Leukocytes, Mononuclear |
Source PubMed
References26
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27912840 | The semaphorins and their receptors as modulators of tumor progression. | Drug Resist Updat | 2016 | https://conductscience.org/library/papers/27912840 | PubMed |
| 2 | 12123608 | Plexin-B1 directly interacts with PDZ-RhoGEF/LARG to regulate RhoA and growth cone morphology. | Neuron | 2002 | https://conductscience.org/library/papers/12123608 | PubMed |
| 3 | 35269896 | Genetic Biomarkers and Their Clinical Implications in B-Cell Acute Lymphoblastic Leukemia in Children. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35269896 | PubMed |
| 4 | 35401878 | Soluble Sema4D Level Is Positively Correlated with Sema4D Expression in PBMCs and Peripheral Blast Number in Acute Leukemia. | Dis Markers | 2022 | https://conductscience.org/library/papers/35401878 | PubMed |
| 5 | 15124703 | Rationale and design of Total Therapy Study XV for newly diagnosed childhood acute lymphoblastic leukemia. | Ann Hematol | 2004 | https://conductscience.org/library/papers/15124703 | PubMed |
| 6 | 24572378 | Survival improvement by decade of patients aged 0-14 years with acute lymphoblastic leukemia: a SEER analysis. | Sci Rep | 2014 | https://conductscience.org/library/papers/24572378 | PubMed |
| 7 | 14692523 | Acute myelogenous leukemia with t(8;21)--identification of a specific immunophenotype. | Leuk Lymphoma | 2003 | https://conductscience.org/library/papers/14692523 | PubMed |
| 8 | 11114375 | Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signaling. | Immunity | 2000 | https://conductscience.org/library/papers/11114375 | PubMed |
| 9 | 12133937 | Requirement for the lymphocyte semaphorin, CD100, in the induction of antigen-specific T cells and the maturation of dendritic cells. | J Immunol | 2002 | https://conductscience.org/library/papers/12133937 | PubMed |
| 10 | 27022279 | The role of semaphorin 4D as a potential biomarker for antiangiogenic therapy in colorectal cancer. | Onco Targets Ther | 2016 | https://conductscience.org/library/papers/27022279 | PubMed |
| 11 | 10982779 | The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis. | Gastroenterology | 2000 | https://conductscience.org/library/papers/10982779 | PubMed |
| 12 | 12094248 | Antigen expression patterns reflecting genotype of acute leukemias. | Leukemia | 2002 | https://conductscience.org/library/papers/12094248 | PubMed |
| 13 | 27729799 | The role of semaphorin 4D in tumor development and angiogenesis in human breast cancer. | Onco Targets Ther | 2016 | https://conductscience.org/library/papers/27729799 | PubMed |
| 14 | 31819303 | Frequency of Cytogenetic Findings and its Effect on the Outcome of Pediatric Acute Lymphoblastic Leukemia. | Med Arch | 2019 | https://conductscience.org/library/papers/31819303 | PubMed |
| 15 | 11369643 | Functional soluble CD100/Sema4D released from activated lymphocytes: possible role in normal and pathologic immune responses. | Blood | 2001 | https://conductscience.org/library/papers/11369643 | PubMed |
| 16 | 28816021 | CD155 knockdown promotes apoptosis via AKT/Bcl-2/Bax in colon cancer cells. | J Cell Mol Med | 2018 | https://conductscience.org/library/papers/28816021 | PubMed |
| 17 | 4179068 | Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. | Scand J Clin Lab Invest Suppl | 1968 | https://conductscience.org/library/papers/4179068 | PubMed |
| 18 | 14534257 | The transmembrane semaphorin Sema4D/CD100, an inhibitor of axonal growth, is expressed on oligodendrocytes and upregulated after CNS lesion. | J Neurosci | 2003 | https://conductscience.org/library/papers/14534257 | PubMed |
| 19 | 35794581 | SEMA4D/PlexinB1 promotes AML progression via activation of PI3K/Akt signaling. | J Transl Med | 2022 | https://conductscience.org/library/papers/35794581 | PubMed |
| 20 | 17855350 | Plexin-B1 utilizes RhoA and Rho kinase to promote the integrin-dependent activation of Akt and ERK and endothelial cell motility. | J Biol Chem | 2007 | https://conductscience.org/library/papers/17855350 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| SEMA4D | 10507 | PubTator's text mining | https://conductscience.org/library/genes/10507 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41998221
GET https://conductscience.org/api/papers/v1/41998221/references?page=2